| |
| |
|
| Insider
Information: |
Gorlin Steve |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
2,272,172 |
|
|
Indirect Shares
|
6,060,392 |
|
|
| Direct
Value |
$889,811 |
|
|
|
Indirect Value
|
$6,360,756 |
|
|
| Total
Shares |
8,332,564 |
|
|
| Total
Value |
$7,250,567 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
8
|
2
|
|
Stock
price went up :
|
8
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
8.0
|
-2.0
|
| Percentage
Gain/Loss : |
 73.9%
|
 -158.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medivation Inc |
MDVN |
Director, 10% Owner |
|
0 |
2005-06-08 |
2,657,317 |
Premium* |
|
|
Mimedx Group Inc |
MDXG |
Director |
2013-05-16 |
11,500 |
2013-05-16 |
886,645 |
Premium* |
|
|
Point Therapeutics Inc |
POTP |
Director |
|
0 |
2008-02-12 |
2,271,330 |
Premium* |
|
|
Medovex Corp. |
MDVX |
Director within last 9... |
2017-10-30 |
1,640,704 |
2014-12-18 |
125,000 |
Premium* |
|
|
Ontrak, Inc |
OTRK |
Director |
2015-10-16 |
450,000 |
2018-06-15 |
100,000 |
Premium* |
|
|
ImmunityBio, Inc |
IBRX |
Director |
2019-06-06 |
92,592 |
2018-11-29 |
0 |
Premium* |
|
|
PolarityTE, Inc |
PTE |
Director |
2019-08-06 |
31,018 |
|
0 |
Premium* |
|
|
Biovie Inc. |
BIVI |
Director |
2023-12-01 |
46,358 |
2020-10-15 |
20,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2009-08-04 |
4 |
S |
$0.00 |
$0 |
I/I |
(450,504) |
2,155,987 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2012-03-02 |
4 |
S |
$1.00 |
$250,000 |
I/I |
(250,000) |
1,601,857 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2012-06-29 |
4 |
S |
$1.55 |
$1,550,000 |
I/I |
(1,000,000) |
601,857 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2012-09-10 |
4 |
S |
$2.70 |
$195,210 |
D/D |
(72,300) |
11,500 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2012-11-02 |
4 |
S |
$2.86 |
$110,638 |
I/I |
(38,300) |
563,557 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2012-11-05 |
4 |
S |
$2.87 |
$112,659 |
I/I |
(39,000) |
524,557 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2012-11-06 |
4 |
S |
$2.89 |
$65,603 |
I/I |
(22,700) |
501,857 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2013-04-17 |
4 |
S |
$4.99 |
$99,800 |
I/I |
(20,000) |
481,857 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2013-05-16 |
4 |
S |
$6.46 |
$193,800 |
I/I |
(30,000) |
451,857 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2015-08-21 |
4 |
S |
$23.00 |
$10,350,000 |
I/I |
(450,000) |
221,720 |
0 |
- |
|
| MDVX |
Medovex Corp. |
|
– • – |
2016-12-01 |
4 |
S |
$1.75 |
$450,000 |
D/D |
(257,143) |
704,360 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2017-09-08 |
4 |
S |
$6.12 |
$90,117 |
D/D |
(14,723) |
375,002 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2017-09-11 |
4 |
S |
$6.03 |
$321,468 |
D/D |
(53,307) |
321,695 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2017-09-12 |
4 |
S |
$6.03 |
$215,833 |
D/D |
(35,811) |
285,884 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2017-09-13 |
4 |
S |
$5.93 |
$234,729 |
D/D |
(39,604) |
246,280 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-15 |
4 |
S |
$4.13 |
$110,890 |
I/I |
(26,835) |
494,885 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-16 |
4 |
S |
$4.05 |
$65,634 |
I/I |
(16,200) |
478,685 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-17 |
4 |
S |
$4.00 |
$154,929 |
I/I |
(38,708) |
439,977 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-18 |
4 |
S |
$3.97 |
$63,413 |
I/I |
(15,971) |
424,006 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-21 |
4 |
S |
$3.90 |
$21,672 |
I/I |
(5,557) |
418,449 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-22 |
4 |
S |
$3.81 |
$32,560 |
I/I |
(8,546) |
409,903 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-24 |
4 |
S |
$3.96 |
$1,200 |
I/I |
(303) |
409,600 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-25 |
4 |
S |
$3.97 |
$14,294 |
I/I |
(3,600) |
406,000 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-29 |
4 |
S |
$3.89 |
$8,175 |
I/I |
(2,100) |
403,900 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-05-30 |
4 |
S |
$3.88 |
$10,564 |
I/I |
(2,724) |
401,176 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
